Skip to content
Home/Companies/Biotech/Minos Biosciences

Minos Biosciences

Biotech·France·Active·13yr hold
Entry
2013
Hold
13yr
Status
Active

Who owns Minos Biosciences?

Minos Biosciences is a French Biotech company, currently owned by Elaia Partners since 2013.

Hand-verified · updated 2026-09-30

Open JSON · CC-BY
Elaia Partners
Investor
Elaia Partners
Elaia Alpha Fund · 2012 · VC

Key facts

HQFrance
SectorBiotech

More from Elaia Alpha Fund

Other portfolio companies in the same fund.

Argosim
Exited 2019
DevToolsFrance· 2016
to Dassault Systèmes
Mediego
Exited 2019
SoftwareFrance· 2016
to Welcoming Group
C-Radar (DataPublica)
Exited 2017
Data & AnalyticsFrance· 2014
to Sidetrade
Cryptosense
Exited 2022
CybersecurityFrance· 2014
to SandboxAQ
Niland
Exited 2017
AI/MLFrance· 2013
to Spotify

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS

Questions

Who owns Minos Biosciences?

Minos Biosciences is currently owned by Elaia Partners, through Elaia Alpha Fund, since 2013.

When did Elaia Partners acquire Minos Biosciences?

Elaia Partners acquired Minos Biosciences in 2013.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue